Click here to download the Guidance for Reviews of Zika-Related Fatalities (PDF).
Webinar “Fatality Review of Deaths of Infants, Children and Youth with Disabilities and Special Health Care Needs”
To be presented February 8, 2017
Approximately one-fifth of the cases reviewed by CDR teams and entered into the CDR-Case Reporting System are deaths of children with disabilities and/or special health care needs. Infants and children with disabilities/special health care needs have different risks for death than their peers without these conditions. To conduct effective reviews of such deaths, CDR and FIMR teams need knowledge of disability/special health care needs in order to determine what role, if any, the disability/special health care needs played in the death.
For more information, download the invitation.
To register, go to https://attendee.gotowebinar.com/register/5045473422233320196.
Archive of Webinar “Building Effective Partnerships for Review”
Presented January 12, 2017
Strong and diverse partnerships are the foundation of a successful mortality review team. Partnerships are vital for all aspects of mortality review work, including reviewing deaths, abstracting and collecting data and identifying and implementing prevention recommendations. This webinar will focus on identifying and engaging new partners, identifying methods for improving collaboration with existing partners, and best practices in partnership building.
For archives of our previous webinars, go to our Archived Webinars page under “Tools for Teams”
Webinar: “Recognizing and Responding to Vicarious Trauma in Fatality Review”
Presented December 14, 2016
Webinar: “Effective Review of Natural Infant Deaths”
Presented November 16, 2016
Click here for our December 2016 Newsletter.
This website was made possible in part by Cooperative Agreement Number UG7MC28482 from the US Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB). Its contents are solely the responsibility of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.